Mode
Text Size
Log in / Sign up

Which antibiotic regimens are being compared to treat Helicobacter pylori infection in children aged 4 to 13 years?

high confidence  ·  Last reviewed May 12, 2026

For children with Helicobacter pylori infection, choosing the right antibiotic regimen is important because antibiotic resistance can make standard treatments less effective. In children aged 4 to 13 years, research has compared two main types of regimens: standard triple therapy (a proton pump inhibitor plus two antibiotics) and bismuth-containing quadruple therapy (which adds bismuth to triple therapy). The studies show that bismuth quadruple therapy often leads to higher eradication rates, especially when clarithromycin resistance is present.

What the research says

A retrospective study of children aged 4–13 years compared two triple therapy regimens: PPI + amoxicillin + clarithromycin (94 children) and PPI + metronidazole + clarithromycin (34 children), given for 10–14 days 3. Another study compared 14-day triple therapy (PPI + clarithromycin + amoxicillin) with 14-day bismuth-containing quadruple therapy (adding colloidal bismuth subcitrate) in 161 children 4. The bismuth quadruple therapy achieved a significantly higher eradication rate (90.36%) compared to triple therapy (74.36%) 4. A larger real-world analysis of 4,610 pediatric patients also found that bismuth quadruple therapy was superior, particularly in cases with clarithromycin resistance 1. The updated 2023 ESPGHAN/NASPGHAN guidelines recommend antimicrobial susceptibility testing to guide therapy in children 9. While these studies focus on children, broader meta-analyses in adults show that vonoprazan-based regimens and bismuth quadruple therapy are among the most effective first-line options 1011.

What to ask your doctor

  • Which antibiotic regimen is best for my child based on local resistance patterns?
  • Should my child have a stool test or endoscopy to check for antibiotic resistance before starting treatment?
  • What are the possible side effects of bismuth quadruple therapy compared to triple therapy?
  • How will we confirm that the infection is gone after treatment?
  • If the first treatment fails, what are the next options?

This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.